Madrigal Pharma Exec Sells $570K in Stock Amid Analyst Focus by Mark Eisenberg 15.06.2024 Waltermire sells 2,000 shares at $285 each, netting $570K; Madrigal Pharmaceuticals sees mixed analyst reports with H.C. Wainwright lowering its ...
John Cox Becomes CEO at Dyne Therapeutics by Mark Eisenberg 29.03.2024 Dyne Therapeutics appoints new CEO, George Eliades, and other key executives as it prepares for growth. Robert Coffin to step ...